Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial

Pawel Rasinski, Siri af Burén, Maria Holstensson, Ted Nilsson, Louiza Loizou, Thuy A. Tran, Ernesto Sparrelid, J. Matthias Löhr and Rimma Axelsson
Journal of Nuclear Medicine August 2023, 64 (8) 1232-1237; DOI: https://doi.org/10.2967/jnumed.123.265481
Pawel Rasinski
1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
2Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siri af Burén
1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
2Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Holstensson
1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
2Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ted Nilsson
2Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louiza Loizou
1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
3Department of Radiology, Karolinska University Hospital, Huddinge, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thuy A. Tran
4Department of Oncology–Pathology, Karolinska Institutet, Stockholm, Sweden;
5Department of Radiopharmacy, Karolinska University Hospital, Stockholm, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernesto Sparrelid
1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
6Department of Upper Gastrointestinal Diseases, Karolinska University Hospital, Huddinge, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Matthias Löhr
1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
6Department of Upper Gastrointestinal Diseases, Karolinska University Hospital, Huddinge, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rimma Axelsson
2Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden;
7Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 8 1232-1237
DOI 
https://doi.org/10.2967/jnumed.123.265481
PubMed 
37348917

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 18, 2023
  • Revision received April 14, 2023
  • Published online August 1, 2023.

Article Versions

  • previous version (June 22, 2023 - 06:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Pawel Rasinski1,2,
  2. Siri af Burén1,2,
  3. Maria Holstensson1,2,
  4. Ted Nilsson2,
  5. Louiza Loizou1,3,
  6. Thuy A. Tran4,5,
  7. Ernesto Sparrelid1,6,
  8. J. Matthias Löhr1,6 and
  9. Rimma Axelsson2,7
  1. 1Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden;
  2. 2Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden;
  3. 3Department of Radiology, Karolinska University Hospital, Huddinge, Sweden;
  4. 4Department of Oncology–Pathology, Karolinska Institutet, Stockholm, Sweden;
  5. 5Department of Radiopharmacy, Karolinska University Hospital, Stockholm, Sweden;
  6. 6Department of Upper Gastrointestinal Diseases, Karolinska University Hospital, Huddinge, Sweden; and
  7. 7Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
  1. For correspondence or reprints, contact Rimma Axelsson (rimma.axelsson{at}ki.se).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 6 Citations
  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
    Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen, Jean-Luc Van Laethem
    Biomedicines 2024 12 3
  • A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
    Marinus J. Hagens, Pim J. van Leeuwen, Maurits Wondergem, Thierry N. Boellaard, Francesco Sanguedolce, Daniela E. Oprea-Lager, Axel Bex, André N. Vis, Henk G. van der Poel, Laura S. Mertens
    Journal of Nuclear Medicine 2024 65 6
  • FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?
    Irene García Megías, Ludmila Santiago Almeida, Adriana K. Calapaquí Terán, Kim M. Pabst, Ken Herrmann, Francesco Giammarile, Roberto C. Delgado Bolton
    Annals of Nuclear Medicine 2025 39 5
  • The Role of FAPI PET Imaging in Pancreatic Cancer: A Meta-analysis Compared with 18F-FDG PET
    Xianwen Hu, Xiaotian Li, Pan Wang, Jiong Cai
    Academic Radiology 2025 32 1
  • Acquisition Duration Optimization Using Visual Grading Regression in [68Ga]FAPI-46 PET Imaging of Oncologic Patients
    Ted Nilsson, Pawel Rasinski, Örjan Smedby, Siri af Burén, Ernesto Sparrelid, J. Matthias Löhr, Thuy A. Tran, August Blomgren, Antonios Tzortzakakis, Rimma Axelsson, Maria Holstensson
    Journal of Nuclear Medicine Technology 2024 52 3
  • FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview
    Zhaoguo Lin, Pawel Rasinski, Ted Nilsson, Maria Holstensson, Yangmeihui Song, August Blomgren, Warissara Jutidamrongphan, Kalyani Pandya, Jimin Hong, Axel Rominger, Kuangyu Shi, Rimma Axelsson, Xiaoli Lan, Robert Seifert
    Seminars in Nuclear Medicine 2025
  • Quantification of the immunohistochemical staining of fibroblast activation protein in intrathoracic solitary fibrous tumors using QuPath
    Akiisa Omura, Toru Kimura, Tomohiro Maniwa, Tadashi Watabe, Keiichiro Honma, Yasushi Shintani, Jiro Okami
    Surgery Today 2025

Article usage

Article usage: June 2023 to April 2025

AbstractFullPdf
Jun 202312595338
Jul 20235694020
Aug 202311765447
Sep 20235623026
Oct 20232786425
Nov 202310419352
Dec 2023608632
Jan 20245913645
Feb 20243823038
Mar 20242719270
Apr 2024259037
May 20242410931
Jun 20241912148
Jul 20242714855
Aug 20242312946
Sep 2024134127
Oct 2024178134
Nov 2024147829
Dec 2024129152
Jan 2025188546
Feb 20251618337
Mar 2025189438
Apr 2025128839
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (8)
Journal of Nuclear Medicine
Vol. 64, Issue 8
August 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial
Pawel Rasinski, Siri af Burén, Maria Holstensson, Ted Nilsson, Louiza Loizou, Thuy A. Tran, Ernesto Sparrelid, J. Matthias Löhr, Rimma Axelsson
Journal of Nuclear Medicine Aug 2023, 64 (8) 1232-1237; DOI: 10.2967/jnumed.123.265481

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial
Pawel Rasinski, Siri af Burén, Maria Holstensson, Ted Nilsson, Louiza Loizou, Thuy A. Tran, Ernesto Sparrelid, J. Matthias Löhr, Rimma Axelsson
Journal of Nuclear Medicine Aug 2023, 64 (8) 1232-1237; DOI: 10.2967/jnumed.123.265481
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Acquisition Duration Optimization Using Visual Grading Regression in [68Ga]FAPI-46 PET Imaging of Oncologic Patients
  • A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • fibroblast activation protein
  • PET/CT
  • pancreatic cancer
  • 68Ga-FAPI-46
SNMMI

© 2025 SNMMI

Powered by HighWire